HK Stock MarketDetailed Quotes
01177 SINO BIOPHARM
- 3.250
- -0.010-0.31%
Market Closed Nov 29 16:08 CST
61.07BMarket Cap13.60P/E (TTM)
3.290High3.220Low41.82MVolume3.260Open3.260Pre Close135.80MTurnover0.22%Turnover Ratio23.72P/E (Static)18.79BShares4.25052wk High1.70P/B61.07BFloat Cap2.23052wk Low0.06Dividend TTM18.79BShs Float10.900Historical High0.050Dividend LFY2.15%Amplitude-0.677Historical Low3.247Avg Price1000Lot Size1.85%Div YieldTTM1.54%Div Yield LFY
SINO BIOPHARM Key Stats
EPS
According to the latest financial report of SINO BIOPHARM, the latest earnings per share (TTM) for the company is 0.18. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out SINO BIOPHARM's latest financial report to see how much their book value per share (BVPS) is currently at 1.92.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of SINO BIOPHARM shows that the company's current ratio is 1.15, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of SINO BIOPHARM, the quick ratio is 1.07, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of SINO BIOPHARM? The latest ROE figure is 9.50%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of SINO BIOPHARM, the total asset return on investment (ROA) is 4.61%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check SINO BIOPHARM's latest financial report to see how their gross margin is doing - currently at 82.08%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of SINO BIOPHARM, the net profit margin is 29.02%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data